Is glycated haemoglobin a sensitive index to identify left ventricular dysfunction two months after acute myocardial

Abdul-Majeed Salmasi1, Peter Frost, Mark Dancy

  • 1Cardiac Research Unit, Cardiology Department, Pathology, Central Middlesex Hospital, Acton Lane, London NW10 7NS, United Kingdom. majeed.salmasi@nwlh.nhs.uk

Insights

Glycated haemoglobin (HbA1c) levels correlate with left ventricular (LV) systolic and diastolic function two months after acute myocardial infarction (AMI). Higher HbA1c predicts impaired LV relaxation and is specific for non-restrictive LV filling.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Cardiac Imaging

Background:

  • Glycated haemoglobin (HbA1c) reflects glucose metabolism.
  • Glucose intolerance is linked to left ventricular (LV) dysfunction post-acute myocardial infarction (AMI).
  • This study investigates HbA1c in relation to LV function in non-diabetic patients after AMI.

Purpose of the Study:

  • To assess the relationship between HbA1c and LV function.
  • To evaluate HbA1c as a predictor of diastolic and systolic dysfunction post-AMI.
  • To analyze HbA1c in normotensive patients without prior diabetes diagnosis following AMI.

Main Methods:

  • Oral glucose tolerance test (GTT) and HbA1c measurements.
  • Echocardiography and Doppler-cardiography to assess LV function parameters (E/A, DT, LVEF, LV mass index).
  • Evaluation of LV diastolic function at rest and during isometric exercise (IME).

Main Results:

  • HbA1c >6.0% was observed in 67% of patients with impaired LV relaxation during IME.
  • HbA1c showed 68% sensitivity and 37% specificity for predicting impaired LV relaxation.
  • HbA1c was significantly related to LVEF, DT, and E/A, but not LV mass index or other clinical factors.

Conclusions:

  • HbA1c correlates with both systolic and diastolic LV function two months post-AMI.
  • HbA1c is a sensitive predictor of impaired LV relaxation.
  • HbA1c is highly specific for ruling out non-restrictive LV filling post-AMI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...